UnitedHealth Group (UNH) vs S&P 500: Which Is the Better Investment?
Quick Answer
For most long-term investors, the S&P 500 (via ETFs like VOO or SPY) remains the superior core investment due to its inherent diversification, lower volatility, and consistent historical compounding. However, UnitedHealth Group (UNH) presents a compelling satellite position for investors seeking targeted exposure to the healthcare sector, dividend growth, and aggressive share repurchases.
While the S&P 500 has delivered robust, steady gains—returning 23% in 2024, 16% in 2025, and roughly 11% to 13% in the first half of 2026 [3, 10]—UNH has experienced significant volatility. After a challenging 2025 where the stock dropped 33%, UNH has rebounded sharply in 2026, up over 26% year-to-date as of July [4, 10]. Ultimately, choosing between the two depends on your risk tolerance: the S&P 500 offers a smoother ride, while UNH requires the stomach for single-stock volatility and regulatory headwinds.
Current Stock Price & Valuation
As of July 2026, UnitedHealth Group is trading near $418 per share [9]. The company's valuation presents an interesting dichotomy for analysts. On a trailing basis, UNH looks relatively expensive, carrying a price-to-earnings (P/E) ratio of roughly 31.9 [10]. However, markets are forward-looking. The stock trades at a much more reasonable forward P/E of 23.22 [9], reflecting strong anticipated earnings growth.
Financially, UnitedHealth remains a juggernaut. Over the last twelve months (LTM) ending in mid-2026, the company generated a staggering $449.6 billion in total revenues and $16.6 billion in consolidated net income [1]. The company's LTM diluted earnings per share (EPS) stands at $17.51 [1], with full-year 2026 Zacks Consensus Estimates projecting earnings of $18.32 per share [9]. Furthermore, UNH offers a dividend yield of approximately 3.0% and a robust free cash flow yield of 6.6% [3].
Detailed Analysis
Historical Returns Comparison
When comparing UNH to the broader market, the divergence in recent years is stark. The S&P 500 has been on a historic run, posting returns of 27% in 2021, 24% in 2023, 23% in 2024, and 16% in 2025 [3].
Conversely, UNH has seen wild swings. After a massive 45% return in 2021, the stock cooled off, returning 7% in 2022, 1% in 2023, and -2% in 2024 [3]. The real shock came in 2025, when UNH shares plummeted 33% [4]. However, 2026 has marked a massive turnaround, with UNH surging over 26% year-to-date by July [10]. Over a 5-year and 10-year horizon, the S&P 500 has provided a much more consistent upward trajectory, whereas UNH has trailed 57% of its managed healthcare peers over the last five years [4].
Volatility and Risk
Single-stock risk is the primary differentiator here. UNH is highly susceptible to regulatory news and sector-specific shocks. For example, in May 2025, UNH suffered a sharp selloff, falling 23% in a single week (including an 18% drop in one day) [6]. Historically, during severe market shocks, UNH has experienced maximum drawdowns as deep as 72% [10].
The S&P 500, by contrast, spreads its risk across 500 large-cap U.S. companies. Its maximum drawdown during the brutal 2022 bear market was limited to 25% [3].
Diversification and Concentration Risk
Investing in an S&P 500 index fund like SPY or VOO provides instant diversification across technology, healthcare, financials, and consumer goods. Interestingly, by owning the S&P 500, you already own UnitedHealth Group; UNH currently makes up about 0.55% of the S&P 500 index [4]. Buying individual shares of UNH concentrates your capital into the managed healthcare space, exposing you heavily to U.S. Medicare/Medicaid policy changes and medical cost inflation.
Fees and Tax Efficiency
From a cost perspective, S&P 500 ETFs are incredibly efficient, often charging expense ratios as low as 0.03%. While buying individual UNH shares incurs no ongoing expense ratio, managing a portfolio of individual stocks can lead to higher transaction costs and less tax efficiency if you are actively trading to rebalance, compared to the internal, tax-free rebalancing of an ETF.
Bull Case
The bullish argument for UnitedHealth Group in July 2026 centers on its massive scale, improving margins, and aggressive shareholder returns.
- Earnings Momentum: UNH reported a blowout second quarter in July 2026, with adjusted EPS surging 56% year-over-year to $6.38, crushing consensus estimates of $4.91 [2].
- Improving Margins: A critical metric for health insurers is the medical cost ratio. UNH successfully drove this down to 86.7% in Q2 2026, a significant improvement from 89.4% in the prior-year period [2].
- Shareholder Yield: The company is aggressively buying back its own stock, expecting to execute at least $5 billion in share repurchases in 2026, having already deployed $4 billion by mid-July [4]. Combined with a 3.0% dividend yield [3], the total shareholder return profile is highly attractive.
Bear Case
The bear case for UNH revolves around regulatory headwinds and valuation premiums.
- Medicare Star Ratings: The most significant dark cloud over UNH is the deterioration in its 2027 Medicare Star Ratings, published by the CMS. This downgrade is projected to create a massive $1.5 billion revenue headwind in 2028 due to lost quality bonus payments [4].
- Valuation: Despite the forward multiple looking reasonable, a trailing P/E of 31.9 [10] means the stock is priced for perfection. Any slip in execution or unexpected spikes in medical utilization could trigger a severe multiple compression.
Key Metrics Summary
| Metric | UnitedHealth Group (UNH) | S&P 500 (SPY/VOO) |
|---|---|---|
| Current Price / Level | ~$418.00 [9] | ~5,500+ |
| 2026 YTD Return (July) | +26.5% [10] | +11% to +13% [4, 10] |
| 2025 Return | -33% [4] | +16% [3] |
| Dividend Yield | 3.0% [3] | ~1.3% |
| Forward P/E | 23.22 [9] | ~21.0 |
| Max Drawdown (Recent) | -72% (Historical) [10] | -25% (2022) [3] |
| Diversification | Single Company (Healthcare) | 500 U.S. Large-Cap Companies |
Frequently Asked Questions
Why did UNH stock drop so much in 2025?
UNH experienced a severe 33% decline in 2025 [4]. This was driven by a combination of rising medical cost ratios, broader sector rotations, and a specific 23% plunge in May 2025 that heavily impacted price-weighted indices like the Dow Jones [6].
How does UNH's dividend compare to the S&P 500?
UNH currently offers a dividend yield of roughly 3.0% [3], which is significantly higher than the S&P 500's average yield of around 1.3%. Furthermore, UNH has a strong track record of growing its dividend annually, supported by a 6.6% free cash flow yield [3].
Will the Medicare Star Ratings downgrade ruin UNH's profitability?
While the 2027 Medicare Star Ratings deterioration is a serious issue—projected to cause a $1.5 billion revenue headwind in 2028 [4]—it is important to contextualize this against UNH's massive scale. With LTM revenues approaching $450 billion [1], a $1.5 billion hit represents less than 0.5% of total revenue. It is a headwind, but not an existential threat.
Final Verdict
Is UNH a better investment than the S&P 500? For the vast majority of investors, No. The S&P 500 remains the superior choice for core portfolio holdings due to its unmatched diversification, lower volatility, and consistent compounding. The S&P 500 protects investors from the severe single-stock drawdowns that UNH has exhibited, such as its 33% drop in 2025 [4].
However, for active investors looking to generate alpha or increase their portfolio's dividend yield, UNH is a highly attractive satellite position. Following its strong Q2 2026 earnings beat and improving medical cost ratios [2], the stock has regained its footing. If you have a long time horizon and can stomach the regulatory volatility inherent to the healthcare sector, buying UNH at a forward P/E of 23.22 [9] offers a compelling entry point into one of the world's most dominant healthcare enterprises.
Ready to Analyze Your Next Investment?
Get a free AI-powered fair value analysis on any stock. See intrinsic value, margin of safety, and institutional-grade risk metrics in seconds. No credit card required.
Want full access to our institutional research tools? Explore Invest Daily Pro.
You're learning technical analysis. See how AI reads a live chart right now.
Upload any stock chart or enter a ticker and our AI identifies key patterns, support/resistance levels, trend strength, and flags potential entry/exit zones.
Watch: Related Videos
from Invest DailyGet This Analysis in Your Inbox Every Morning
Get our daily market briefing with institutional-grade analysis, key developments, and actionable strategy - delivered before the opening bell.
Essential Reading: Top Investor Guides
Our most comprehensive guides - start here to build a complete investing foundation.
Market Basics
Stock Market Fundamentals: How Markets Work, Reading Charts, and Technical Analysis
Portfolio Strategy
Portfolio Management Masterclass: Asset Allocation, Diversification, and Rebalancing
Retirement
The Complete Retirement Planning Guide: 401(k), IRA, Roth, and FIRE Strategy
Dividend Income
The Ultimate Guide to Dividend Investing: How to Build a Safe Income Portfolio
Valuation
The Complete Guide to Stock Valuation: How to Calculate Intrinsic Value
Financial Statements
How to Read a Balance Sheet Like a Professional Analyst
Monetary Policy
Understanding the Federal Reserve: How Monetary Policy Actually Works
Real Estate
Real Estate Investment Trusts (REITs): A Complete Investor's Guide
Options & Hedging
Options Basics: How to Use Derivatives to Protect Your Portfolio
Investor Psychology
